Navigation Links
Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer
Date:9/21/2009

ets); tiredness; stomach upset, including nausea, vomiting, and diarrhea; mouth, throat, or lip sores; loss of appetite; rash; and constipation.

Call your healthcare professional right away if you have a fever, chills, diarrhea, or mouth sores. These symptoms could mean you have an infection. These are not all of the side effects of ALIMTA. If you have any side effect that bothers you or that does not go away, be sure to talk with your healthcare professional.

You will have regular blood tests before and during your treatment with ALIMTA. Your doctor may adjust your dose of ALIMTA or delay your treatment based on the results of your blood test and on your general condition.

For more information about all of the side effects of ALIMTA, please talk with your healthcare team, see the Patient Prescribing Information and full Prescribing Information, visit www.ALIMTA.com, or call 1-800-545-5979.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

This press release contains forward-looking statements about the potential of ALIMTA for the treatment of non-small cell lung cancer and reflects Lilly's current beliefs. There is no guarantee that the product will continue to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

(Logo: http://www.newscom.com/cgi-bin/prnh/
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...ASHINGTON, Nov. 21 DNC ...after the Senate voted to begin full debate of hea...ttp://www.newscom.com/cgi-bin/prnh/20080519/DNCLOG...ic step on the road to enacting health insurance r...enators will now have an opportunity to debate the...
(Date:11/21/2009)... LONDON, November 21, 2009 /PRNewswire-FirstCall/ ...st Test Test Test Test Test Test Test Test Test,Te...st Test Test Test Test,Test Test Test Test Test Te...est More test More test More test More test More t...est More test More test More test More,test More t...
(Date:11/21/2009)... New Haven Dental Group merges their p...ranford, CT. , (PRWEB) No...prised of partners Dr. David Gibson, Dr. Dean Clou...has just merged their growing practice with that o...en Dr. Pickman decided he wanted to retire from de...
(Date:11/20/2009)..., WASHINGTON, Nov. 20 ...rged the Senate to make essential changes its heal...aw on abortion funding and conscience protection o...grants and include strong provisions for adequate ... health care bill an "enormous disappointment" tha...
(Date:11/20/2009)... ST. LOUIS, Nov. 20 Ce...hat it will present at the Bank of America Merrill... 2-3, 2009, at the Crowne Plaza Hotel Times Square...esday, December 2nd at 8:30 a.m. Eastern Time. Inv...ive, audio webcast of Centene,s presentation at: ...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:New Haven Dental Group Expands Their Vision 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2
...he dangers of sun exposure that are backed by rese...a person's risk of developing skin// cancer, Ameri...ublished in the Journal of the American Academy of...ercent increase since 1999. However, this percenta...
...alth (MOH) says that Singapore will soon conduct a...mic Readiness.// More than 1,000 personnel ... the Ministry of Education, the Civil Aviation Aut... The two-day emergency exercise endeavors to si...
...earchers, in collaboration with investigators at J...rial to test// a new vaccine against the West Nile...cause serious illness, is making its yearly appear...ille have tested positive for the virus. "Wh...
... memory begins to decline, executive function is t...ession from mild cognitive// impairment, a pre-Alz.... Ron Petersen, M.D., Ph.D., Mayo Clinic neu...omeone with mild cognitive impairment starts havin...
... admissions given to 23 students in a post-graduat...rrent academic year. // "The division bench ...eld that the college administration had not conduc... behalf of two students who had filed a case again...
... Roche are conducting talks to make the expensive ...able.// According to Health Minister Tony Abbo...the delay in rushing Herceptin on to the Pharmaceu...ossible deal for patients. So we are to some exten...
Other Medicine News:Health News:Age and Socioeconomic Factors Are Strongest Determinants of Sunburn 2Health News:Age and Socioeconomic Factors Are Strongest Determinants of Sunburn 3Health News:University Participating in West Nile Vaccine Trial 2Health News:Decline in Concentration, Decision-Making and Problem-Solving 2
(Date:11/20/2009)...e-FirstCall/ -- Biotel Inc. (OTC Bulletin Board: B... September 30, 2009 with net earnings of $128,000,...,000. This compares to net earnings of $328,000, ...000 for the first quarter of last year. ,, Comm...ent and CEO Steve Springrose said: "Biotel enjoyed...
(Date:11/20/2009)... BD (Becton, Dickinson an...letion of its acquisition of HandyLab, Inc., an An...manufactures molecular diagnostic assays and autom...b announced an exclusive agreement for BD to devel...Lab Jaguar(TM) platform, the first fully integrate...
(Date:11/19/2009)...wswire/ -- Warner Chilcott plc (Nasdaq: WCRX ) to...ced secondary offering of 20,000,000 of its ordina...hare. The selling shareholders include funds affi...nking, J.P. Morgan Partners (advised by CCMP Capit...r institutional investors and members of the Compa...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Ikaria 28R 29 Names New Chairman 14523 1Ikaria 28R 29 Names New Chairman 14523 2Hologic Expands Healthcare Investment in Asia 5563 1Hologic Expands Healthcare Investment in Asia 5563 2Hologic Expands Healthcare Investment in Asia 5563 3Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 1Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 2Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 3Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 4Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 5Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 6Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 7
... groups set out to confirm potential benefits of a...th breast cancer, PARIS, May 27 A new internatio...er is open for enrollment. The pivotal BETH,(BEvac...sitive Breast,Cancer) study is a Phase III clinica...s of combining two monoclonal antibodies, the anti...
...on A/S Today Announces That it has Entered Into a ...ity of Texas M. D., Anderson Cancer Center to De... Cancer, VEDBAEK, Denmark...alue gene expression analysis products, today,anno...agreement with the,Kleberg Center for Molecular Ma...
Other Medicine Technology:First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer 2First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer 3First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer 4Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center 2Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center 3
...CellaVision DM96 is an Automated Digital Cell Morp...e-classification/characterization, display, storag...es. Up to 96 stained peripheral blood smears can b... 60 per hour depending on the tests requested. Usi...
Cystoscopy "T". Drape, Sterile
Urological Drape
... the Penilab IV and the Penilab V have an exceptio...tal studies. Model 1060 is similar to the Model 1... can one be added later. The Penilab V has a Dopp... of the accessories you'll need to get started. L...
Medicine Products: